Get started
Author

George Simeakis

Observed name: G. Simeakis
ORCID: 0000-0002-3348-7340
Observed ORCID: 0000-0002-3348-7340
OpenAlex ID: A5031291132
Advanced RAI-refractory thyroid cancer: an update on treatment perspectives
2022 · Olga Karapanou, George Simeakis, et al. · Endocrine Related Cancer · 40
PDF
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib
2022 · Rossella Elisei, Raffaele Ciampi, et al. · The Journal of Clinical Endocrinology & Metabolism · 37
PDF
Different outcomes in sporadic versus familial medullary thyroid cancer
2018 · Katerina Saltiki, George Simeakis, et al. · Head & Neck · 29
MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives
2022 · Katerina Saltiki, George Simeakis, et al. · European Journal of Endocrinology · 20
Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance
2023 · Katerina Saltiki, George Simeakis, et al. · Endocrine · 13
Medullary thyroid carcinoma (MTC): unusual metastatic sites
2021 · Paraskevi Kazakou, George Simeakis, et al. · Endocrinology Diabetes and Metabolism Case Reports · 11
PDF
Familial MTC with RET exon 8 Gly533Cys mutation: origin and prevalence of second malignancy
2017 · Katerina Saltiki, Elli Anagnostou, et al. · Endocrine Connections · 7
PDF
High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study
2023 · George Simeakis, Maria Anagnostouli, et al. · Biomedicines · 5
PDF
Predictive Factors of Lymph Node Metastasis in Papillary Thyroid Microcarcinoma (PTMC)
2025 · Odysseas Violetis, Maria Sfakiotaki, et al. · Medicina · 3
PDF
Short-term effect of tirzepatide on serum calcitonin in adults with obesity
2026 · Nikolaos Angelopoulos, George Simeakis, et al. · Endocrine · 1
Differentiated high-grade thyroid carcinoma (DHGTC) and poorly differentiated TC (PDTC): diagnostic and therapeutic challenges in the precision medicine era - report of two cases
2025 · Aikaterini Kapama, Kyriakos Vamvakidis, et al. · Endocrine Abstracts · 1
Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer: Initial Experience in Greece
2025 · George Simeakis, Aikaterini Kapama, et al. · Biomedicines · 1
PDF
Histology is more ιmportant than persistent anti‐Tg antibodies for progression of differentiated thyroid cancer
2021 · Olga Karapanou, Katerina Saltiki, et al. · Clinical Endocrinology · 1
Temporal dynamics and prognostic value of serum calcitonin during tirzepatide therapy in adults with obesity
2026 · Nikolaos Angelopoulos, George Simeakis, et al. · Obesity Research & Clinical Practice
Disease Burden, Surveillance, and Treatment Gaps in Chronic Hypoparathyroidism: Insights From a Multicenter Registry
2026 · Rodis D. Paparodis, Ioannis Androulakis, et al. · Endocrine Practice
Multimodal liquid biopsy (MMLB) in sporadic medullary thyroid carcinoma (SPMTC) patients: a pilot study
2026 · George Simeakis, Elina Lagopodi, et al. · Endocrine Abstracts
Lobectomy for sporadic medullary thyroid carcinoma (SPMTC): first reported case in greece
2026 · George Simeakis, Maria Mpogiatzidou, et al. · Endocrine Abstracts
Genetic landscape of a series of sporadic differentiated thyroid carcinoma (SPDTC) patients: clinical utility of next generation sequencing (NGS) in therapeutic strategy
2026 · George Simeakis, Pantelis Constantoulakis, et al. · Endocrine Abstracts
P445 - LBA_ECE_1014 - Real-world disease burden and care gaps in chronic hypoparathyroidism: results from the multicentre Greek OPA registry
2026 · Rodis Paparodis, Ioannis Androulakis, et al. · European Journal of Endocrinology
PDF
P192 - ECE_1332 - Early changes in serum calcitonin during tirzepatide therapy in adults with obesity
2026 · Nicholas Angelopoulos, George Simeakis, et al. · European Journal of Endocrinology
PDF
P426 - ECE_3821 - Epigenetic silencing of RASSF1A, MGMT and NALCN in plasma cfDNA of sporadic medullary thyroid carcinoma patients
2026 · George Simeakis, Konstantina Tekou, et al. · European Journal of Endocrinology
PDF
Part 1: The Role of Thyroglobulin Antibodies in Thyroid Cancer Development and Aggressiveness
2026 · Rodis D. Paparodis, Evangelos Karvounis, et al. · Cancers
PDF
SAT-343 The Role of Preoperative Titers of Thyroglobulin Antibodies in Thyroid Cancer: Data from a Multicentric International Collaboration
2025 · Rodis D Paparodis, Evangelos Karvounis, et al. · Journal of the Endocrine Society
PDF
SAT-342 Interim Analysis of AIBx Software for Thyroid Cancer Diagnosis from Ultrasound Images. A Multicenter International Study
2025 · Rodis D Paparodis, Andreas Rizoulis, et al. · Journal of the Endocrine Society
PDF
SAT-344 The Effect of Preexisting Diabetes on the Risk and Features of Thyroid Cancer in Patients Undergoing Thyroidectomy: An International Multicentric Study
2025 · Rodis D Paparodis, Evangelos Karvounis, et al. · Journal of the Endocrine Society
PDF
Works count: 55
Citation count: 169
H-index: 7
I10-index: 6
Year
Topic
Type